Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer

White Plain Hospital, White Plains

North Shore Hematology Oncology Associates, East Setauket

Hudson Valley Hematology Oncology Associates, Poughkeepsie

Magee Womens Hospital of UPMC, Pittsburgh

West Virginia University, Morgantown

Waverly Hematology Oncology, Cary

Charleston Cancer Center, Charleston

Carolina Blood and Cancer Care Associates PA, Rock Hill

AMPM Research Clinic, Miami Gardens

FL Cancer Research Institute, Plantation

Bond Clinic, P.A., Winter Haven

Clearview Cancer Center, Huntsville

Hattiesburg Clinic Hematology Oncology, Hattiesburg

Ohio State University, Columbus

Aultman Hospital, Canton

Franciscan St. Francis Health, Indianapolis

St. Vincent Frontier Cancer Center, Billings

Washington University, St Louis

The University of Kansas Cancer Center and Medical Pavilion, Westwood

Oklahoma Cancer Specialists & Research Institute, LLC, Tulsa

Scott & White Memorial Hospital, Temple

Oncology Consultants, P.A., Houston

The University of Texas Health Science Center at San Antonio, San Antonio

SAMMC - Hem/Onc Clinic, Houston

Texas Oncology-McAllen, McAllen

Innovative Clinical Research Institute, Whittier

PacificShores Medical Group, Long Beach

Alliance Research Centers, Laguna Hills

Pacific Cancer Medical Center, Inc., Anaheim

Valley Medical Oncology Consultants, Pleasanton

Marin Cancer Care, Inc, Greenbrae

Triple Army Medical Cente, Honolulu

Northwest Medical Specialties, PLLC, Tacoma

Providence Regional Cancer System, Lacey

Medical Oncology Associates, PS, Spokane